Ajinomoto Bio-Pharma Services India Profile
Key Indicators
- Authorised Capital ₹ 95.00 Cr
- Paid Up Capital ₹ 85.76 Cr
- Company Age 13 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 185.20 Cr
- Revenue Growth -36.29%
- Profit Growth -148.71%
- Ebitda -42.92%
- Net Worth -5.42%
- Total Assets 49.33%
About Ajinomoto Bio-Pharma Services India
Ajinomoto Bio-Pharma Services India Private Limited (ABSIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 02 September 2011 and has a history of 13 years and eight months. Its registered office is in Paravada, Andhra Pradesh, India.
The Corporate was formerly known as Granules Omnichem Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 95.00 Cr and a paid-up capital of Rs 85.76 Cr.
The company has closed loans amounting to ₹185.20 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Ajinomoto Bio-Pharma Services India Private Limited India are Baipaneni Alekhya as COMPANY SECRETARY and Srivenkata Kuchi as Cfo. Mark Cassidy, Venkata Kakarlapudi, Patrick Craene, and One other member serve as directors at the Company.
Company Details
- Location
Paravada, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233TG2011PTC076274
- Company No.
076274
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Sep 2011
- Date of AGM
08 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Pharma
Ajinomoto Bio-Pharma Services India Private Limited
Explore comprehensive data for Ajinomoto Bio-Pharma Services India Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Ajinomoto Bio-Pharma Services India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Kakarlapudi  | Managing Director | 29-May-2020 | Current |
| Baipaneni Alekhya | Company Secretary | 29-May-2020 | Current |
| Srivenkata Kuchi | CFO | 28-Jun-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mark Cassidy  | Director | 20-Jun-2017 | Current |
Patrick Craene  | Director | 10-Jun-2021 | Current |
| Els Roeland | Director | 14-Apr-2023 | Current |
Financial Performance of Ajinomoto Bio-Pharma Services India.
Ajinomoto Bio-Pharma Services India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 36.29% decrease. The company also saw a substantial fall in profitability, with a 148.71% decrease in profit. The company's net worth dipped by a decrease of 5.42%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ajinomoto Bio-Pharma Services India?
In 2023, Ajinomoto Bio-Pharma Services India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹185.20 Cr
Charges Breakdown by Lending Institutions
- Deg - Deutsche Investitions - Und Entwicklungsgesellschaft Mbh : 62.10 Cr
- Ing Bank Nv Singapore Branch : 62.10 Cr
- Others : 61.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Oct 2016 | Others | ₹61.00 Cr | Satisfied |
| 23 Apr 2013 | Deg - Deutsche Investitions - Und Entwicklungsgesellschaft Mbh | ₹62.10 Cr | Satisfied |
| 23 Apr 2013 | Ing Bank Nv Singapore Branch | ₹62.10 Cr | Satisfied |
How Many Employees Work at Ajinomoto Bio-Pharma Services India?
Ajinomoto Bio-Pharma Services India has a workforce of 159 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ajinomoto Bio-Pharma Services India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ajinomoto Bio-Pharma Services India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Ajinomoto Bio-Pharma Services India
Recent activity within the organization
- Annual General Meeting
Ajinomoto Bio-Pharma Services India Private Limited last Annual general meeting of members was held on 08 Sep 2023 as per latest MCA records.
- Director Appointment
Els Roeland was appointed as a Director was appointed as a Director on 14 Apr 2023 & has been associated with this company since 2 years 28 days .
- Balance Sheet
Ajinomoto Bio-Pharma Services India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Vijayawada.
- Director Appointment
Srivenkata Subrahmanya Sarma Kuchi was appointed as a Cfo was appointed as a Cfo on 28 Jun 2022 & has been associated with this company since 2 years 10 months .
- Director Appointment
Patrick Juliaan E De Craene was appointed as a Director was appointed as a Director on 10 Jun 2021 & has been associated with this company since 3 years 11 months .
- Director Appointment
Venkata Viswanadha Raju Kakarlapudi was appointed as a Managing Director was appointed as a Managing Director on 29 May 2020 & has been associated with this company since 4 years 11 months .
Recent News, Updates & Announcement
- Ajinomoto Bio-Pharma to Acquire Joint Venture Granules OmniChem in India.
The transaction will reach completion during the fourth quarter of 2019. .
Frequently asked questions
What is the Incorporation or founding date of Ajinomoto Bio-Pharma Services India Private Limited?
Ajinomoto Bio-Pharma Services India Private Limited was incorporated on 02 Sep 2011.
What is authorized share capital and paid-up capital of Ajinomoto Bio-Pharma Services India Private Limited?
The authorized share capital of Ajinomoto Bio-Pharma Services India Private Limited is ₹ 95.00 Cr and paid-up capital is ₹ 85.76 Cr.
Who are the current board members & directors of Ajinomoto Bio-Pharma Services India Private Limited?
Currently 6 directors are associated with Ajinomoto Bio-Pharma Services India Private Limited.
- Mark Adam Cassidy
- Venkata Viswanadha Raju Kakarlapudi
- Patrick Juliaan E De Craene
- Els Roeland
- Baipaneni Alekhya
- Srivenkata Subrahmanya Sarma Kuchi
What is the registered address of Ajinomoto Bio-Pharma Services India Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Ajinomoto Bio-Pharma Services India Private Limited is Plot Nos.121(Part) & 122Ramky Pharma City India Private Limited, Sez Parawada Lankelapalem, Paravada, Andhra Pradesh, 531019.
What is the corporate identification number (CIN) and company number of Ajinomoto Bio-Pharma Services India Private Limited?
The corporate identification number (CIN) of Ajinomoto Bio-Pharma Services India Private Limited is U24233TG2011PTC076274 and the company number is 076274 as per Ministry of Corporate Affairs (MCA).
What is the official website of Ajinomoto Bio-Pharma Services India Private Limited?
The Official website of Ajinomoto Bio-Pharma Services India Private Limited is https://www.ajibio-pharma.com
What has been the recent revenue trend for Ajinomoto Bio-Pharma Services India Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Ajinomoto Bio-Pharma Services India Private Limited has fallen by -36.29%.
How many employees does Ajinomoto Bio-Pharma Services India Private Limited currently have?
As Per 2023 financial reports, 159 employees are currently employed by Ajinomoto Bio-Pharma Services India Private Limited.
What change has been observed in the net worth of Ajinomoto Bio-Pharma Services India Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Ajinomoto Bio-Pharma Services India Private Limited has experienced an downturn of -5.42%.
When was the last Balance Sheet of Ajinomoto Bio-Pharma Services India Private Limited filed with the ROC?
The most recent Balance Sheet for Ajinomoto Bio-Pharma Services India Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Peter StuyckDirector- Peter StuyckNominee Director
Venkata VadaliDirector
Chigurupati PrasadNominee Director
Jean AgnusDirector
George BompasNominee Director
Venkatanaga RajuNominee DirectorHC
Harsha ChigurupatiNominee Director
Similar Companies Based on API Manufacturers
Mylan Laboratories Limited Hyderabad, Telangana, India
Sun Pharmaceutical Industries Limited Vadodara, Gujarat, India
Msn Laboratories Private Limited Rangareddy, Telangana, India
Lupin Limited Mumbai, Maharashtra, India
Ipca Laboratories Limited Mumbai, Maharashtra, India
Divi's Laboratories Limited Rangareddy, Telangana, India
Hetero Labs Limited Rangareddy, Telangana, India
Glenmark Pharmaceuticals Limited Mumbai, Maharashtra, India